Etoposide (Pfizer) نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

etoposide (pfizer)

pharmacia limited company trading as pharmacia - etoposide 20mg - solution for injection - 20 mg/ml - active: etoposide 20mg excipient: citric acid ethanol macrogol 300 polysorbate 80

Etoposide (Pacific) نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

etoposide (pacific)

viatris limited - etoposide 20 mg/ml - solution for infusion - 100 mg/5ml - active: etoposide 20 mg/ml excipient: benzyl alcohol citric acid ethanol macrogol 300 nitrogen polysorbate 80

ETOPOSIDE INJECTION 100 mg5 ml سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

etoposide injection 100 mg5 ml

pfizer private limited - etoposide - injection - 100 mg/5 ml - etoposide 100 mg/5 ml

Etoposide Injection 100 mg/5 mL (1) أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

etoposide injection 100 mg/5 ml (1)

pfizer (perth) pty ltd - etoposide, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute - - small cell carcinoma of the lung. - acute monocytic and myelomonocytic leukaemia. - hodgkin's disease - non-hodgkin's lymphoma.

Etoposide 100 mg/5 mL Injection (Bulk) أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

etoposide 100 mg/5 ml injection (bulk)

pfizer (perth) pty ltd - etoposide, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute - for the treatment of small cell lung cancer and testicular tumours, either as a single agent or in combination with other anticancer agents.

Etoposide injection 100 mg in 5 mL (3) أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

etoposide injection 100 mg in 5 ml (3)

pfizer (perth) pty ltd - etoposide, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute - etoposide is primarily used for the treatment of testicular tumours, in combination with bleomycin and cisplatin, and in combination with cisplatin for small-cell carcinoma of the lung. it is also active against non-hodgkin?s lymphomas, acute nonlymphocytic leukemia, carcinoma of the breast and kaposi?s sarcoma associated with acquired immunodeficiency syndrome (aids).

Hx-Etoposide 1000mg/50ml ناميبيا - الإنجليزية - Namibia Medicines Regulatory Council

hx-etoposide 1000mg/50ml

sandoz sa (pty) ltd - etoposide - solution for infusion - each 50ml solution contains etoposide 1000.0 mg

Hx-Etoposide 400mg/20ml ناميبيا - الإنجليزية - Namibia Medicines Regulatory Council

hx-etoposide 400mg/20ml

sandoz sa (pty) ltd - etoposide - solution for infusion - each 20ml solution contains etoposide 400.0 mg

Hx-Etoposide 50mg/2.5ml ناميبيا - الإنجليزية - Namibia Medicines Regulatory Council

hx-etoposide 50mg/2.5ml

sandoz sa (pty) ltd - etoposide - solution for infusion - each 2.5ml solution contains etoposide 50.0 mg

Hx-Etoposide 200mg/10ml ناميبيا - الإنجليزية - Namibia Medicines Regulatory Council

hx-etoposide 200mg/10ml

sandoz sa (pty) ltd - etoposide - solution for infusion - each 10ml solution contains etoposide 200.0 mg